Adoport 0,5 mg trde kapsule Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adoport 0,5 mg trde kapsule

lek d.d. - takrolimus - kapsula, trda - takrolimus 0,5 mg / 1 kapsula - takrolimus

Adoport 0,75 mg trde kapsule Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adoport 0,75 mg trde kapsule

lek d.d. - takrolimus - kapsula, trda - takrolimus 0,75 mg / 1 kapsula - takrolimus

Adoport 2 mg trde kapsule Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adoport 2 mg trde kapsule

lek d.d. - takrolimus - kapsula, trda - takrolimus 2 mg / 1 kapsula - takrolimus

Adoport 5 mg trde kapsule Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adoport 5 mg trde kapsule

lek d.d. - takrolimus - kapsula, trda - takrolimus 5 mg / 1 kapsula - takrolimus

Descovy Evrópusambandið - slóvenska - EMA (European Medicines Agency)

descovy

gilead sciences ireland uc - emtricitabine, tenofovir alafenamide - okužbe z virusom hiv - antivirusi za sistemsko uporabo - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).

Vocabria Evrópusambandið - slóvenska - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Rekambys Evrópusambandið - slóvenska - EMA (European Medicines Agency)

rekambys

janssen-cilag international nv - rilpivirine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.